IL5 and nasal cavity polyp: IL-5 and IL-13 levels were significantly increased in the nasal polyps of patients with eCRSwNP (both P < 0.001) or noeCRSwNP (both P < 0.001), compared with control tissues (Figures 5(b) and 5(c)).